SKI Market

Indian Indices

Sensex

85,762.01 573.41
( 0.67%)

Global Indices

Nasdaq

48,084.29 -303.78
(-0.63%)

Dow Jones

6,866.50 -50.74
(-0.73%)

Hang Seng

50,384.39 -142.53
(-0.28%)

Nikkei 225

9,967.75 36.37
(0.37%)

Forex

USD-INR

89.87 0.03
(0.03%)

EUR-INR

105.50 -0.18
(-0.17%)

GBP-INR

120.91 -0.28
(-0.23%)

JPY-INR

0.57 0.00
(-0.26%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Hikal Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

524735

INE475B01022

96.8412723

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

HIKAL

273.49

2798.93

EPS(TTM)

Face Value()

Div & Yield %

0.83

0.35

Back

nalwa sons investments ltd

W H Brady & Co consolidated net profit declines 27.15% in the June 2025 quarter

Aug 09,2025

Net profit of W H Brady & Co declined 27.15% to Rs 2.20 crore in the quarter ended June 2025 as against Rs 3.02 crore during the previous quarter ended June 2024. Sales declined 2.72% to Rs 23.58 crore in the quarter ended June 2025 as against Rs 24.24 crore during the previous quarter ended June 2024.

Particulars	Quarter Ended
	Jun. 2025	Jun. 2024	% Var.
Sales	23.58	24.24	-3
OPM %	7.25	13.82	-
PBDT	4.20	5.23	-20
PBT	3.58	4.82	-26
NP	2.20	3.02	-27

85,762.01 573.41 ( 0.67%)

48,084.29 -303.78 (-0.63%)

6,866.50 -50.74 (-0.73%)

50,384.39 -142.53 (-0.28%)

9,967.75 36.37 (0.37%)

89.87 0.03 (0.03%)

105.50 -0.18 (-0.17%)

120.91 -0.28 (-0.23%)

0.57 0.00 (-0.26%)